By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tesaro, Inc. (Waltham, Massachusetts) 

309 Waverley Oaks Road
Suite #101
Waltham  Massachusetts  02452  U.S.A.
Phone: 339-970-0900 Fax: n/a



Company News
Tesaro (TSRO) Announces Submission Of Investigational New Drug Application For Anti-TIM-3 Antibody TSR-022 To The FDA 4/25/2016 9:29:27 AM
Tesaro (TSRO) To Announce First Quarter 2016 Financial Results On May 5, 2016 4/22/2016 8:39:27 AM
Massachusetts' Tesaro (TSRO) Inks $450 Million Prostate Cancer Deal with Drug Giant Johnson & Johnson (JNJ) 4/6/2016 6:38:47 AM
Tesaro (TSRO) Announces Appointment Of Dr. Kavita Patel To Board Of Directors 4/4/2016 9:51:40 AM
Tesaro (TSRO) Announces Enrollment Of First Patient In Phase 1 Clinical Trial Of TSR-042 3/29/2016 9:50:19 AM
Tesaro (TSRO) And MD Anderson Cancer Center Announce Immuno-Oncology Collaboration And Exclusive License Agreement 3/29/2016 9:46:21 AM
Tesaro (TSRO) Announces Validation Of Marketing Authorization Application For Oral Rolapitant By European Medicines Agency 3/23/2016 9:31:59 AM
Tesaro (TSRO) Announces Closing Of $155 Million Private Placement 3/21/2016 9:03:03 AM
Tesaro (TSRO) Submits New Drug Application For Intravenous Rolapitant To The U.S. FDA 3/14/2016 10:45:49 AM
Tesaro (TSRO) Announces Definitive Agreement For $155 Million Private Placement 2/26/2016 9:08:44 AM